You are here

  • Home
  • Archive
  • Volume 15, Issue 4
  • STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

Article info

Article menu

Download PDFPDF

Neurology
Protocol
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

Authors

  • Carlos Delfino Centro de Estudios Clínicos, Instituto de Ciencias e Innovación en Medicina (ICIM), Universidad del Desarrollo Facultad de Medicina Clínica Alemana, Las Condes, Chile PubMed articlesGoogle scholar articles
  • Cheryl Carcel Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Xiaolei Lin Data science, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Paula Muñoz-Venturelli Centro de Estudios Clínicos, Instituto de Ciencias e Innovación en Medicina (ICIM), Universidad del Desarrollo Facultad de Medicina Clínica Alemana, Las Condes, ChileFaculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Sharon L Naismith Charles Perkins Centre and The University of Sydney, The University of Sydney Brain and Mind Centre, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Mark Woodward Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, AustraliaSchool of Public Health, Imperial College London, The George Institute for Global Health UK, Oxford, Oxfordshire, UK PubMed articlesGoogle scholar articles
  • Ruth Peters Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Nirupama Wijesuriya Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Meng Law Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Ian H Harding Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Xia Wang Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Julian Elliott Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Karin Leder Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Owen Hutchings Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ximena Stecher Departamento de Imagenología, Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Clinica Alemana de Santiago SA, Vitacura, Metropolitan Region, Chile PubMed articlesGoogle scholar articles
  • Sophia Zoungas Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Craig S Anderson Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, AustraliaRoyal Prince Alfred Hospital, Camperdown, New South Wales, AustraliaInstitute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai, Shanghai, China PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Craig S Anderson; canderson{at}georgeinstitute.org.au
View Full Text

Citation

Delfino C, Carcel C, Lin X, et al
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection
BMJ Open 2025;15:e089382. doi: 10.1136/bmjopen-2024-089382

Publication history

  • Received May 28, 2024
  • Accepted March 28, 2025
  • First published April 14, 2025.
Online issue publication 
April 14, 2025
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.